News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,287 Results
Type
Article (88691)
Company Profile (816)
Press Release (792752)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233553)
Career Advice (4161)
Deals (39966)
Drug Delivery (175)
Drug Development (91662)
Employer Resources (207)
FDA (18543)
Job Trends (17478)
News (398640)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3049)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (188)
Alliances (56988)
ALS (228)
Alzheimer's disease (1954)
Antibody-drug conjugate (ADC) (528)
Approvals (18859)
Artificial intelligence (841)
Autoimmune disease (342)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (209)
Brain cancer (84)
Breast cancer (818)
Cancer (6352)
Cardiovascular disease (544)
Career advice (3595)
Career pathing (51)
CAR-T (369)
CDC (76)
Celiac Disease (3)
Cell therapy (1039)
Cervical cancer (51)
Clinical research (78687)
Collaboration (2305)
Company closure (8)
Compensation (1462)
Complete response letters (103)
COVID-19 (3036)
CRISPR (120)
C-suite (1240)
Cystic fibrosis (166)
Data (8352)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (647)
Diagnostics (7547)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (413)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (311)
Earnings (102456)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138113)
Executive appointments (1173)
FDA (22507)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1888)
Gene editing (266)
Generative AI (87)
Gene therapy (841)
GLP-1 (1258)
Government (5553)
Grass and pollen (8)
Guidances (415)
Healthcare (21180)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (351)
Immuno-oncology (108)
Indications (197)
Infectious disease (3423)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (308)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (116)
Layoffs (682)
Leadership (52)
Legal (10171)
Liver cancer (109)
Longevity (36)
Lung cancer (835)
Lymphoma (446)
Machine learning (65)
Management (66)
Manufacturing (1183)
MASH (219)
Medical device (15253)
Medtech (15391)
Mergers & acquisitions (23249)
Metabolic disorders (1734)
mRNA (258)
Multiple sclerosis (202)
NASH (24)
Neurodegenerative disease (488)
Neuropsychiatric disorders (125)
Neuroscience (3645)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5139)
Now hiring (80)
Obesity (833)
Opinion (371)
Ovarian cancer (238)
Pain (281)
Pancreatic cancer (326)
Parkinson's disease (404)
Partnered (39)
Patents (638)
Patient recruitment (724)
Peanut (67)
People (67860)
Pharmaceutical (136)
Pharmacy benefit managers (36)
Phase 1 (24318)
Phase 2 (34181)
Phase 3 (25694)
Pipeline (9297)
Policy (394)
Postmarket research (3559)
Preclinical (10947)
Press Release (72)
Prostate cancer (330)
Psychedelics (68)
Radiopharmaceuticals (362)
Rare diseases (1224)
Real estate (7461)
Recruiting (81)
Regulatory (30229)
Reports (78)
Research institute (2765)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1289)
Venture capital (128)
Weight loss (574)
Women's health (136)
Worklife (24)
Date
Today (208)
Last 7 days (644)
Last 30 days (3715)
Last 365 days (33134)
2026 (14643)
2025 (33225)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (394)
Arkansas (16)
Asia (52176)
Australia (9176)
California (14076)
Canada (3943)
China (1498)
Colorado (603)
Connecticut (621)
Delaware (432)
Europe (120329)
Florida (2083)
Georgia (461)
Hawaii (4)
Idaho (69)
Illinois (1200)
India (100)
Indiana (651)
Iowa (25)
Japan (570)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1710)
Massachusetts (10267)
Michigan (421)
Minnesota (785)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3729)
New Mexico (34)
New York (3687)
North Carolina (1903)
North Dakota (11)
Northern California (6976)
Ohio (437)
Oklahoma (26)
Oregon (55)
Pennsylvania (2789)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5511)
Tennessee (223)
Texas (2282)
United States (50332)
Utah (421)
Vermont (1)
Virginia (357)
Washington D.C. (88)
Washington State (1158)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,287 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
May 28, 2026
·
6 min read
Press Releases
BPGbio to Present Ongoing Phase 2 Study Trial-in-Progress Update of BPM31510 in Newly Diagnosed Glioblastoma at ASCO 2026
May 28, 2026
·
4 min read
Press Releases
Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD
May 28, 2026
·
10 min read
Press Releases
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
May 28, 2026
·
8 min read
Press Releases
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
May 28, 2026
·
12 min read
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
Kailera Therapeutics is advancing a pipeline of weight loss medicines that mirror that of Eli Lilly’s: an injectable GLP-1/GIP dual agonist like Zepbound, an oral GLP-1 like Foundayo and a triple-G therapy like retatrutide.
May 28, 2026
·
2 min read
·
Tristan Manalac
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
May 28, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
May 28, 2026
·
8 min read
Press Releases
Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life’s VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology
May 28, 2026
·
3 min read
Press Releases
BeOne Medicines Receives Positive Reimbursement Recommendations from CDA-AMC and INESSS for TEVIMBRA in First-Line Nasopharyngeal Carcinoma
May 28, 2026
·
11 min read
1 of 88,229
Next
